Investment
Features
FeesSafety
Academy
More
Pluang+

Compare W W Grainger Inc (GWW) vs Nuwellis Inc (NUWE) Price & Performance

W W Grainger IncTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

W W Grainger Inc vs Nuwellis Inc — how do they compare? W W Grainger Inc trades at $1,309.36 (market cap $61.32B), while Nuwellis Inc trades at $1.41 (market cap $542.80K). The key difference: W W Grainger Inc is far larger — about 112969.8× Nuwellis Inc's market cap, and W W Grainger Inc pays a 0.77% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.

GWWNUWE
Market Cap
$61.32B$542.80K
Sector
TechnologyTechnology
52-Week High
$1.40K$220.50
52-Week Low
$918.18$1.42
Enterprise Value
$63.53B-$1.27M
Dividend Yield
0.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

W W Grainger Inc

W.W. Grainger (GWW) trades at $1,299.53, showing modest daily gains of 0.16%. The stock demonstrates strong fundamental performance with Q2 2026 earnings beating estimates at $12.01 per share versus $11.30 expected, and revenue reaching $5 billion. Technical indicators show bearish momentum with the current price between support at $1,282 and resistance at $1,305. The company raised its full-year 2026 outlook following strong quarterly results driven by margin expansion and market share gains.

GWW presents a mixed investment case with strong profitability metrics (ROE 47.92%, net margin 9.92%) offset by premium valuation (P/E 33.19). Analyst consensus leans cautious with 65.79% hold ratings despite recent earnings beats. Key risks include valuation concerns and competitive pressures in industrial distribution. The $1,320 consensus price target suggests limited upside from current levels, requiring careful monitoring of margin sustainability.

Nuwellis Inc

NUWE trades at $1.43, up 0.7% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of -$17.52M in 2025, with a negative net income margin of -217.22%, though recent news highlights product development and revenue growth initiatives, including a 14% preliminary year-over-year revenue increase in Q2 2026.

Outlook is cautious due to persistent losses and high cash burn, but growth in pediatric installations and strategic expansions offer potential. Risks include financial sustainability and competitive pressures, while analyst coverage is limited with a split buy/hold consensus.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About W W Grainger Inc

Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.

Read more on GWW

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE